Relay Therapeutics Inc RLAY

US Biotechnology

$17.47 ▼ -1.47% ($-0.26)

🔥 High Short Interest

Open $17.94

Prev Close $17.73

Day Range $17.42 – $18.01

52W Range $4.32 – $21.27

Market Cap $3.83B

Beta 1.73

EPS (TTM) $-1.57

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-07-16
Shares Out.	215,560,000
Website	relaytx.com/ ↗
Phone	13026587581
Employees	192
Revenue	$350,000
Gross Profit	$350,000
Net Income	-$83.7M
Free Cash Flow	-$212.2M
Total Assets	$967.5M
Total Liabilities	$77.4M
Equity	$890.0M

About Relay Therapeutics Inc

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Relay Therapeutics Inc is a publicly traded company under the ticker symbol RLAY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.